Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice.

Chiriac MT, Licarete E, Sas AG, Rados AM, Lupan I, Chiriac AM, Speth H, Pop-Vancia V, Domsa I, Sesarman A, Popescu O, Sitaru C.

Orphanet J Rare Dis. 2013 Jan 29;8:17. doi: 10.1186/1750-1172-8-17.

2.

The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

Oswald E, Sesarman A, Franzke CW, Wölfle U, Bruckner-Tuderman L, Jakob T, Martin SF, Sitaru C.

PLoS One. 2012;7(2):e31066. doi: 10.1371/journal.pone.0031066. Epub 2012 Feb 6.

3.

Pathogenesis of bullous pemphigoid.

Ujiie H, Nishie W, Shimizu H.

Immunol Allergy Clin North Am. 2012 May;32(2):207-15, v. doi: 10.1016/j.iac.2012.04.001. Epub 2012 Apr 17.

PMID:
22560134
4.

IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.

Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT.

Hum Immunol. 2014 Apr;75(4):354-63. doi: 10.1016/j.humimm.2014.01.005. Epub 2014 Jan 24.

PMID:
24468586
5.

[Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"].

Nishie W, Shimizu H.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Dec;32(6):472-7. Review. Japanese.

6.

Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.

Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H.

J Invest Dermatol. 2002 Mar;118(3):485-92.

7.

Pathogenesis of bullous pemphigoid.

Ujiie H, Nishie W, Shimizu H.

Dermatol Clin. 2011 Jul;29(3):439-46, ix. doi: 10.1016/j.det.2011.03.008. Review.

PMID:
21605809
8.

Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.

Natsuga K, Nishie W, Shinkuma S, Ujiie H, Nishimura M, Sawamura D, Shimizu H.

J Immunol. 2012 Jun 1;188(11):5792-9. doi: 10.4049/jimmunol.1003402. Epub 2012 Apr 20.

9.

Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.

Nishie W.

Methods Mol Biol. 2013;961:363-9. doi: 10.1007/978-1-62703-227-8_24.

PMID:
23325657
10.
11.

Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.

Ujiie H, Sasaoka T, Izumi K, Nishie W, Shinkuma S, Natsuga K, Nakamura H, Shibaki A, Shimizu H.

J Immunol. 2014 Nov 1;193(9):4415-28. doi: 10.4049/jimmunol.1400095. Epub 2014 Sep 26.

12.

Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D.

J Clin Invest. 2005 Apr;115(4):870-8.

13.

Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.

Hirose M, Recke A, Beckmann T, Shimizu A, Ishiko A, Bieber K, Westermann J, Zillikens D, Schmidt E, Ludwig RJ.

J Immunol. 2011 Aug 1;187(3):1176-83. doi: 10.4049/jimmunol.1100596. Epub 2011 Jun 24.

15.

Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.

Leighty L, Li N, Diaz LA, Liu Z.

Arch Dermatol Res. 2007 Nov;299(9):417-22. Epub 2007 Sep 19. Review.

16.

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.

Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C.

J Pathol. 2004 Dec;204(5):519-27.

PMID:
15538734
17.

A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.

Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H.

J Immunol. 2009 Sep 15;183(6):4088-93. doi: 10.4049/jimmunol.0800389. Epub 2009 Aug 28.

18.

Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

Nishie W.

J Dermatol Sci. 2014 Mar;73(3):179-86. doi: 10.1016/j.jdermsci.2013.12.001. Epub 2013 Dec 27. Review.

PMID:
24434029
19.

The role of complement in experimental bullous pemphigoid.

Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, Diaz LA.

J Clin Invest. 1995 Apr;95(4):1539-44.

20.

Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.

Zillikens D, Schmidt E, Reimer S, Chimanovitch I, Hardt-Weinelt K, Rose C, Bröcker EB, Kock M, Boehncke WH.

J Pathol. 2001 Jan;193(1):117-24.

PMID:
11169524

Supplemental Content

Support Center